George Ansstas

12PUBLICATIONS

73CO-AUTHORS

Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursMolecular targets

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (12)

Sort by Publication Date:

|Jun 01, 2026

Intismeran Autogene Plus Pembrolizumab Versus Pembrolizumab Alone in High-Risk Resected Melanoma: 5-Year Update of the Randomized Phase IIb KEYNOTE-942 Study.

|Mar 25, 2026

NT-I7, a Long-Acting Interleukin 7, Increases Lymphocyte Counts and Induces CD8+ T-cell Clonotype Expansion in Patients with Newly Diagnosed High-Grade Gliomas.

Omar H Butt, Kartik Singhal, Jingqin Luo

|Feb 26, 2026

Laser interstitial thermal therapy and adjuvant pembrolizumab in recurrent high-grade astrocytoma: a Phase 1/randomized Phase 2b trial.

Jian L Campian, Son B Le, Ashley Ghiaseddin

|Feb 03, 2026

Longitudinal ctDNA Monitoring for Postsurgical Disease Surveillance in Patients with Stage I to IIIB Melanoma.

George Ansstas, Karam Khaddour, Sumedha Sudhaman

|Jan 14, 2026

Homologous Recombination Deficiency in Skin Cancers: Prevalence and Clinical Implications of This Distinct Patient Cohort.

George Nassief, Tolulope Adeyelu, Andrew Elliott

|Sep 28, 2024

Recent Advancements in Cell-Based Therapies in Melanoma.

George Nassief, Angela Anaeme, Karen Moussa

Pageof 2

Frequent Collaborators

George Nassief

Karam Khaddour

Jiayi Huang

Milan G Chheda

Omar H Butt

Albert H Kim

Ryan J Sullivan

Alice Y Zhou

Angela Anaeme

Ari Vanderwalde

Frequent Collaborators

George Nassief

Karam Khaddour

Jiayi Huang

Milan G Chheda